HomeCompareRIDE vs JNJ

RIDE vs JNJ: Dividend Comparison 2026

RIDE yields 90.91% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RIDE wins by $2.65M in total portfolio value
10 years
RIDE
RIDE
● Live price
90.91%
Share price
$2.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.67M
Annual income
$842,999.04
Full RIDE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RIDE vs JNJ

📍 RIDE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRIDEJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RIDE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RIDE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RIDE
Annual income on $10K today (after 15% tax)
$7,727.27/yr
After 10yr DRIP, annual income (after tax)
$716,549.18/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RIDE beats the other by $715,845.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RIDE + JNJ for your $10,000?

RIDE: 50%JNJ: 50%
100% JNJ50/50100% RIDE
Portfolio after 10yr
$1.34M
Annual income
$421,913.41/yr
Blended yield
31.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RIDE
Analyst Ratings
1
Hold
6
Sell
Consensus: Sell
Price Target
$22.50
+922.7% upside vs current
Range: $15.00 — $30.00
Altman Z
-32.1
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RIDE buys
0
JNJ buys
0
No recent congressional trades found for RIDE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRIDEJNJ
Forward yield90.91%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$2.67M$20.0K
Annual income after 10y$842,999.04$827.78
Total dividends collected$2.36M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellBuy
Analyst price target$22.50$228.73

Year-by-year: RIDE vs JNJ ($10,000, DRIP)

YearRIDE PortfolioRIDE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$19,791$9,090.91$10,676$355.77+$9.1KRIDE
2$37,991$16,814.71$11,407$389.39+$26.6KRIDE
3$70,817$30,166.17$12,198$426.53+$58.6KRIDE
4$128,326$52,552.16$13,056$467.62+$115.3KRIDE
5$226,308$88,999.24$13,987$513.12+$212.3KRIDE
6$388,835$146,685.82$14,998$563.56+$373.8KRIDE
7$651,597$235,543.05$16,098$619.52+$635.5KRIDE
8$1,066,101$368,892.48$17,295$681.69+$1.05MRIDE
9$1,704,801$564,073.19$18,599$750.82+$1.69MRIDE
10$2,667,136$842,999.04$20,022$827.78+$2.65MRIDE

RIDE vs JNJ: Complete Analysis 2026

RIDEStock

Lordstown Motors Corp. develops, manufactures, and sells Endurance, an electric full-size pickup truck for fleet customers. The company was founded in 2019 and is based in Lordstown, Ohio.

Full RIDE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RIDE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RIDE vs SCHDRIDE vs JEPIRIDE vs ORIDE vs KORIDE vs MAINRIDE vs ABBVRIDE vs MRKRIDE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.